Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years

BACKGROUND: Active monitoring of safety outcomes following COVID-19 vaccination is critical to understand vaccine safety and can provide early detection of rare outcomes not identified in pre-licensure trials. We present findings from an early warning rapid surveillance system in three large commerc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloyd, Patricia C., Hu, Mao, Wong, Hui-Lee, Shoaibi, Azadeh, Ke Zhou, Cindy, Lo, An-Chi, Amend, Kandace, Beachler, Daniel C., McMahill-Walraven, Cheryl N., Smith, Elizabeth R., Seeger, John, Secora, Alex, Djibo, Djeneba Audrey, Obidi, Joyce, Feng, Yuhui, Song, Jennifer, Reich, Christian, Harris, Charalynn, Akhtar, Sandia, Clifford, Robin, Selvam, Nandini, Pigoga, Jennifer L., Jiao, Yixin, Chillarige, Yoganand, MaCurdy, Thomas, Forshee, Richard, Anderson, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513329/
https://www.ncbi.nlm.nih.gov/pubmed/36195472
http://dx.doi.org/10.1016/j.vaccine.2022.09.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513329/
https://www.ncbi.nlm.nih.gov/pubmed/36195472
http://dx.doi.org/10.1016/j.vaccine.2022.09.060

Ejemplares similares